A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 24, 2021

Primary Completion Date

October 20, 2022

Study Completion Date

October 20, 2022

Conditions
Visual ImpairmentAge-Related Macular DegenerationDiabetic RetinopathyGlaucoma
Interventions
OTHER

In-House Developed VR Platform - AMD, DR, Glaucoma

Participants will conduct experiments using commercial VR headsets and controllers. Visual impairments will be systematically simulated in VR. There are three visual impairment simulations (AMD, DR, and glaucoma) at three levels of severity (mild, moderate, or severe). Symptoms' simulation tools include a gaussian blur shader, distortion shader, and a culling mask with a gray spot in the middle.

OTHER

In-House Developed VR Platform - Glaucoma

In the second set of experiments, a multidimensional visual impairment simulation of a single pathology (glaucoma) will be used at three levels of severity (mild, moderate, or severe). The post-processing package to simulate includes glare, difficulty in light, change adaptation, ambient occlusion, visual clutter, and overall blurred effect. The shader graph package will be used to create a distortion localized on assets surfaces only.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT05135195 - A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training | Biotech Hunter | Biotech Hunter